Insider · CIK 0001850404
Haft Nicholas
Reports to the SEC for 1 company · LINCOLNSHIRE, IL
Transactions
16
Companies
1
Filings
4
CIK
0001850404
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-06-08 | FNCHFinch Therapeutics Group, Inc. · Stock Option (right to buy)A Award | — |
| 2022-06-13 | FNCHFinch Therapeutics Group, Inc. · Stock Option (right to buy)A Award | — |
| 2021-12-20 | FNCHFinch Therapeutics Group, Inc.P Purchase | +$650K |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc.C Conversion | — |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc.C Conversion | — |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc.C Conversion | — |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc.C Conversion | — |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc.C Conversion | — |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc.C Conversion | — |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc.P Purchase | +$15M |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc. · Series A Preferred StockC Conversion | — |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc. · Series A Preferred StockC Conversion | — |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc. · Series B Preferred StockC Conversion | — |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc. · Series C Preferred StockC Conversion | — |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc. · Series C Preferred StockC Conversion | — |
| 2021-03-23 | FNCHFinch Therapeutics Group, Inc. · Series D Preferred StockC Conversion | — |
Recent filings
- 4Haft Nicholas0000899243-23-015183SEC(opens sec.gov)
- 4Haft Nicholas0000899243-22-022611SEC(opens sec.gov)
- 4Haft Nicholas0001567619-21-022453SEC(opens sec.gov)
- 4Haft Nicholas0001209191-21-023074SEC(opens sec.gov)
Companies
Address
ONE OVERLOOK POINT, SUITE 100
LINCOLNSHIRE, IL, 60060